Strife C F, Strife J L, Wacksman J
Division of Nephrology, Children's Hospital Medical Center, Cincinnati, OH 45229-2899.
Pediatrics. 1991 Dec;88(6):1238-41.
The natural progression of nephropathic cystinosis to end stage renal disease can be delayed, sometimes by many years, by the reducing agent, cysteamine, which lowers intracellular cystine content to near normal. We report on two patients with nephropathic cystinosis who were treated with cysteamine and developed structural genitourinary abnormalities which may have contributed to an increase in the rate of decline of renal function. One patient, aged 11 years, was found to have massive megacystis and hydroureteronephrosis but no anatomic bladder outlet obstruction. His abnormality was presumed to be related to chronic high urine volumes leading to megacystis and physiologic ureteral obstruction. Vesicostomy stabilized renal function. The second patient, aged 11 1/2 years, was found to have bilateral renal cystic disease which presumably was acquired and may have been related to long-standing hypokalemia. Minor renal abnormalities were found by ultrasound in five additional cystinotic children. We concluded that older children with nephropathic cystinosis may be prone to acquire structural abnormalities of their kidneys or urinary tract.
通过使用还原剂半胱胺,可延缓肾病性胱氨酸病发展至终末期肾病的自然进程,有时能延缓多年,半胱胺可使细胞内胱氨酸含量降至接近正常水平。我们报告了两名接受半胱胺治疗的肾病性胱氨酸病患者,他们出现了泌尿生殖系统结构异常,这可能导致肾功能下降速率加快。一名11岁的患者被发现有巨大膀胱和输尿管肾盂积水,但无解剖学上的膀胱出口梗阻。推测其异常与长期高尿量导致巨大膀胱及生理性输尿管梗阻有关。膀胱造瘘术稳定了肾功能。第二名患者为11岁半,被发现患有双侧肾囊性疾病,推测为后天获得性,可能与长期低钾血症有关。另外五名胱氨酸病患儿经超声检查发现有轻微肾脏异常。我们得出结论,年龄较大的肾病性胱氨酸病患儿可能易于出现肾脏或尿路的结构异常。